Purchase Order 75D30119P05114
Award Date 5/31/19
Potential Completion Date 6/27/19
Potential Value $150K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Portland, OR 97230, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Other Statutory Authority
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Centers for Disease Control and Prevention (CDC) awarded an $82,263 firm fixed price purchase order to Sedia Biosciences Corporation for laboratory supplies and equipment to support rapid recency kits. Sedia Biosciences, doing business as Sedia Biosciences Corp., will deliver the requested supplies and equipment from its location in Chamblee, Georgia to support CDC programs in Pittsburgh, Pennsylvania by December 30, 2023. No subcontractors or set aside designations were identified. The...
- Sedia Biosciences Corporation, doing business as Sedia Biosciences Corp, was awarded a firm fixed price purchase order contract by the Department of Health and Human Services' Centers for Disease Control and Prevention (CDC) to provide Asante rapid recency kits and a reader. The $112,060.00 contract supports CDC disease surveillance and prevention initiatives domestically, with the products being delivered to the CDC's Pittsburgh, Pennsylvania facilities. Sedia Biosciences Corp, a for-profit...
- The Centers for Disease Control and Prevention (CDC) awarded a firm fixed price purchase order to Sedia Biosciences Corporation, a privately held medical device and diagnostics company, to provide Asante HIV-1 Rapid Recency Assays and HIV-1 LAg-Avidity EIA Avidity Kits. The $119,155.00 contract was awarded on September 3, 2020, with a completion date of April 15, 2021. These products are used in the CDC's ongoing HIV surveillance program and are only available from Sedia Biosciences Corporation....
- The U.S. Centers for Disease Control and Prevention (CDC) awarded a $33,840 firm fixed-price purchase order to Sebia, Inc., a global leader in automated electrophoresis technologies, to provide medical equipment, reagents, consumables, testing services, and maintenance support. This award is not set aside and is part of Sebia's broader contract vehicles with the Department of Veterans Affairs (VA) and Department of Defense (DoD) to deliver its specialized clinical laboratory technologies....
- The Centers for Disease Control and Prevention (CDC) Pittsburgh awarded a firm fixed-price purchase order to Premier Medical USA Corp on July 30, 2024, for the supply of SURE STATUS HIV-1 RECENCY TEST kits (25 tests per kit), with a contract ceiling value of $50,450. The contract is not associated with a set-aside designation and will be performed in Somerset, Franklin Township, New Jersey. As a civilian agency contract, this award supports the CDC's public health surveillance and HIV monitoring...
- This federal contract award was made by the Centers for Disease Control and Prevention (CDC) to Life Technologies Corporation, a subsidiary of Thermo Fisher Scientific Inc. The $91,758.84 firm fixed-price purchase order is for the delivery of HIV test kits and supplies. The contract does not have a set-aside designation and has an ultimate completion date of December 31, 2021. Life Technologies Corporation, as the prime contractor, is a leading provider of biomedical research and genetic...
- The CDC Pittsburgh awarded a $88,000 firm fixed-price purchase order to Sebia, Inc. for service and maintenance of a Capillarys 3 DBS (dried blood spot) instrument. The contract, awarded on January 16, 2026, extends through January 14, 2031, and will be performed at the CDC facility in Chamblee, Georgia. No small business set-aside was utilized for this award. Sebia, Inc., headquartered in Norcross, Georgia, is a specialized provider of automated electrophoresis technologies and laboratory...
- The Centers for Disease Control and Prevention (CDC) Pittsburgh awarded a firm fixed-price purchase order to Biomerieux Inc. on July 24, 2024, with a ceiling value of $11,973.13. The contract covers NucliSens reagents designed for use on Biomerieux's sample extraction platforms—specifically the NucliSens EasyMAG, eMAG, and MiniMAG systems—which have been validated for HIV drug resistance testing. These reagents support the Molecular Diagnostic and Surveillance Team's surveillance operations at...
- This definitive contract was awarded by the Centers for Disease Control and Prevention (CDC) to Vela Diagnostics USA Inc. to purchase reagents and consumables for approximately $59,500. The CDC, a component of the Department of Health and Human Services, seeks to protect public health and safety through the control and prevention of disease, injury, and disability. This firm fixed price contract supports the CDC's mission and is being performed in Chamblee, Georgia through August 1, 2023. No set...
- The Centers for Disease Control and Prevention (CDC) awarded a $173,530 purchase order to Meso Scale Discovery of Atlanta, Georgia for lab supplies. As part of its mission to protect public health through control and prevention of infectious diseases, the CDC likely requires these supplies to support research and testing activities. Meso Scale Discovery will deliver the supplies to the CDC's Pittsburgh location by October 20th under a firm fixed price contract. No subcontractors or set aside...